Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Vidarabine (Adenine Arabinoside) 是从链霉菌分离的核苷类抗生素,能抗单纯性疱疹和水痘-带状疱疹病毒。它对 HSV-1 和 HSV-2 的 IC50值分别为 9.3 μg/ml 和 11.3 μg/ml。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
50 mg | ¥ 298 | 现货 | ||
100 mg | ¥ 418 | 现货 | ||
200 mg | ¥ 671 | 现货 | ||
500 mg | ¥ 980 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 460 | 现货 |
产品描述 | Vidarabine (Adenine Arabinoside) is a nucleoside antibiotic isolated from Streptomyces antibioticus. It has some antineoplastic properties and has broad spectrum activity against DNA viruses in cell cultures and significant antiviral activity against infections caused by a variety of viruses such as the herpes viruses, the VACCINIA VIRUS and varicella zoster virus. |
靶点活性 | HSV2:11.3 μg/mL (IC50), HSV1:9.3 μg/mL (IC50) |
体外活性 | Vidarabine and Acyclovir have a synergistic effect on wild type . Vidarabine is capable of inhibiting acyclovir-resistant/TK-deficient mutants of HSV and VZV, because it is phosphorylated to its active vidarabine–triphosphate form by cellular kinases and is not dependent for its activation on the viral TK. [1] Vidarabine and acyclovir (ACV) alone show a concentration-dependent inhibition of plaque formation of HSV-1 in Vero cells. Vidarabine combined with acidic protein bound polysaccharide (APBP) show synergistic effects on the plaque formation of HSV-1 in Vero cells. [2] Vidarabine acts directly on the DNA polymerase of varicella-zoster virus (VZV) and double-strand DNA viruses, including human adenoviruses. Vidarabine specifically inhibits adenovirus type 11 replication without obvious cytotoxicity in vitro. Vidarabine acts less on the synthesis of early proteins but rather on those after DNA replication. [3] Vidarabine is an antiviral drug with activity against herpes viruses, poxviruses, and certain rhabdoviruses, hepadnarviruses, and RNA tumor viruses. Vidarabine also is active against vaccinia virus both in vitro and in vivo. [4] |
体内活性 | Vidarabine is rapidly deaminated to 9-β-D-arabinofuranosyl hypoxanthine (Ara-Hx) as the principal metabolite. [3] |
别名 | Adenine Arabinoside, 阿糖腺苷, 9-β-D-Arabinofuranosyladenine, Vira-A, Arabinosyladenine, Ara-A |
分子量 | 267.24 |
分子式 | C10H13N5O4 |
CAS No. | 5536-17-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 3 mg/mL (11.22 mM)
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 49 mg/mL (183.4 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
H2O / DMSO | 1 mM | 3.742 mL | 18.7098 mL | 37.4195 mL | 93.5489 mL |
5 mM | 0.7484 mL | 3.742 mL | 7.4839 mL | 18.7098 mL | |
10 mM | 0.3742 mL | 1.871 mL | 3.742 mL | 9.3549 mL | |
DMSO | 20 mM | 0.1871 mL | 0.9355 mL | 1.871 mL | 4.6774 mL |
50 mM | 0.0748 mL | 0.3742 mL | 0.7484 mL | 1.871 mL | |
100 mM | 0.0374 mL | 0.1871 mL | 0.3742 mL | 0.9355 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Vidarabine 5536-17-4 Cell Cycle/Checkpoint DNA Damage/DNA Repair Microbiology/Virology Tyrosine Kinase/Adaptors HSV Nucleoside Antimetabolite/Analog Antibiotic Tyrosine Kinases DNA/RNA Synthesis 9-beta-D-Arabinofuranosyladenine Orthopoxvirus Adenine Arabinoside 阿糖腺苷 9-β-D-Arabinofuranosyladenine Inhibitor 9-b-D-Arabinofuranosyladenine Vira-A Arabinosyladenine inhibit Herpes simplex virus Ara-A inhibitor